Low-dose versus standard-dose nivolumab with cabozantinib for first-line treatment of metastatic renal cell carcinoma: a multicentre retrospective study from India (ESMO-IO 2026) - Oct 25, 2026 - Abstract #154P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Metastases • Retrospective data • Genito-urinary Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor
|
|
Debapriya Mondal; Prashant Pandey; Rakesh Roy; Satadru Biswas
|